Bile Acids and FXR: Novel Targets for Liver Diseases is a research paper published in Frontiers in Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 201 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIEHS NIH HHS
Grant: T32 ES007148
National Institutes of Health
Grant: 2T32ES007148-06
TRAINING IN EVIRONMENTAL TOXICOLOGY
National Institutes of Health
Grant: 5R21ES029258-02
Differential roles of FXR and FGF15 in liver fibrosis development
National Institutes of Health
Grant: 5R01GM104037-03
Gut bile acids, Fxr, & Fgf15 in total parenteral nutrition-associated cholestasis
Rutgers, The State University of New Jersey
U.S. Department of Veterans Affairs
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice
Additional file 1 of FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice
Additional file 1 of Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
Additional file 1 of Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
Additional file 1 of Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status
Additional file 1 of Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status